Your browser doesn't support javascript.
loading
The Utility of 18FDG-PET/CT in Diagnosing Fever of Unknown Origin: The Experience of a Large Tertiary Medical Center.
Mahajna, Hussein; Vaknin, Keren; Ben Shimol, Jennifer; Watad, Abdulla; Abu-Much, Arsalan; Mahroum, Naim; Shovman, Ora; Shoenfeld, Yehuda; Amital, Howard; Davidson, Tima.
Afiliação
  • Mahajna H; Department of Medicine 'B', Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan 52621, Israel.
  • Vaknin K; Department of Gastroenterology, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan 52621, Israel.
  • Ben Shimol J; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Watad A; Department of Medicine 'B', Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan 52621, Israel.
  • Abu-Much A; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Mahroum N; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Shovman O; Department of Medicine, E. Wolfson Medical Center, Holon 5822012, Israel.
  • Shoenfeld Y; Department of Medicine 'B', Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan 52621, Israel.
  • Amital H; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Davidson T; Zabludowicz Center for Autoimmune Diseases, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan 52621, Israel.
Article em En | MEDLINE | ID: mdl-34069883
ABSTRACT
Fever of unknown origin (FUO) poses a diagnostic challenge, and 18-fluorodexoyglucose positron emission tomography with computed tomography (18FDG-PET/CT) may identify the source. We aimed to evaluate the diagnostic yield of 18FDG-PET/CT in the work-up of FUO. The records of patients admitted to Sheba Medical Center between January 2013 and January 2018 who underwent 18FDG-PET/CT for the evaluation of FUO were reviewed. Following examination of available medical test results, 18FDG-PET/CT findings were assessed to determine whether lesions identified proved diagnostic. Of 225 patients who underwent 18FDG-PET/CT for FUO work-up, 128 (57%) met inclusion criteria. Eighty (62.5%) were males; mean age was 59 ± 20.3 (range 18-93). A final diagnosis was made in 95 (74%) patients. Of the 128 18FDG-PET/CT tests conducted for the workup of FUO, 61 (48%) were true positive, 26 (20%) false positive, 26 (20%) true negative, and 15 (12%) false negative. In a multivariate analysis, weight loss and anemia were independently associated with having a contributary results of 18FDG-PET/CT. The test yielded a sensitivity of 70%, specificity of 37%, positive predictive value of 70%, and negative predictive value of 37%. 18FDG-PET/CT is a valuable tool in the diagnostic workup of FUO. It proved effective in diagnosing almost half the patients, especially in those with anemia and weight loss.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fluordesoxiglucose F18 / Febre de Causa Desconhecida Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Adult / Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fluordesoxiglucose F18 / Febre de Causa Desconhecida Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Adult / Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article